Up next

Autoplay

Molecular Profile of Acute Myeloid Leukemia (AML)

0 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Timothy A. Graubert, MD, Massachusetts General
Hospital Cancer Center, Harvard Medical School

Comprehensive studies of the acute myeloid leukemia (AML) genome have revealed new insights into the genetic basis of this disease. Recurrently mutated genes fall into pathways previously implicated in AML pathogenesis (e.g., cytokine signaling, line age specific transcription factors) and novel pathways (e.g., RNA splicing, epigenetic regulation, cohesin biology). This increased knowledge provides opportunities to refine prognostic algorithms and has identified new potential targets for therapy.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay